JPM vs MFM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MFM exhibits a stable Piotroski F-Score of 6/9, but this operational stability is overshadowed by severe valuation and sustainability concerns. The current price of $5.35 trades at a significant premium to both the Graham Number ($4.20) and the Intrinsic Value ($0.91). Most critically, the dividend payout ratio of 210.38% indicates that the current yield is unsustainable and not supported by earnings, which have declined by 14.60% YoY. Combined with a bearish technical trend and a high P/E of 41.15, the asset appears overvalued relative to its fundamental growth profile.
Compare Another Pair
Related Comparisons
JPM vs MFM: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and MFS Municipal Income Trust (MFM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.